Tham khảo Trestolone

  1. 1 2 3 4 5 6 7 8 9 J. Elks (14 tháng 11 năm 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. tr. 888–. ISBN 978-1-4757-2085-3.
  2. 1 2 3 4 https://adisinsight.springer.com/drugs/800016155
  3. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 Nieschlag E, Kumar N, Sitruk-Ware R (2013). “7α-methyl-19-nortestosterone (MENTR): the population council's contribution to research on male contraception and treatment of hypogonadism”. Contraception. 87 (3): 288–95. doi:10.1016/j.contraception.2012.08.036. PMID 23063338.
  4. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Sundaram K, Kumar N, Bardin CW (tháng 4 năm 1993). “7 alpha-methyl-nortestosterone (MENT): the optimal androgen for male contraception”. Ann. Med. 25 (2): 199–205. doi:10.3109/07853899309164168. PMID 8489761.
  5. 1 2 3 4 5 6 7 Corona G, Rastrelli G, Vignozzi L, Maggi M (2012). “Emerging medication for the treatment of male hypogonadism”. Expert Opin Emerg Drugs. 17 (2): 239–59. doi:10.1517/14728214.2012.683411. PMID 22612692.
  6. 1 2 Lyster SC, Duncan GW (tháng 7 năm 1963). “Anabolic, androgenic and myotropic activities of derivatives of 7alpha-methyl-19-nortestosterone”. Acta Endocrinol. 43: 399–411. doi:10.1530/acta.0.0430399. PMID 13931986.
  7. 1 2 Ma JB, Li ZS (1990). “[Synthesis of 4-substituted 17 beta-hydroxy-7 alpha-methyl-4-estren-3-one and their 17-acetates as antifertility compounds]”. Yao Xue Xue Bao (bằng tiếng Trung Quốc). 25 (1): 18–23. PMID 2363352.Quản lý CS1: ngôn ngữ không rõ (liên kết)
  8. 1 2 3 Sundaram K, Kumar N, Bardin CW (1994). “7 alpha-Methyl-19-nortestosterone: an ideal androgen for replacement therapy”. Recent Prog. Horm. Res. 49: 373–6. PMID 8146434.
  9. 1 2 MENT – project information from the Population Council
  10. Anderson RA, Wallace AM, Sattar N, Kumar N, Sundaram K (tháng 6 năm 2003). “Evidence for tissue selectivity of the synthetic androgen 7 alpha-methyl-19-nortestosterone in hypogonadal men”. J. Clin. Endocrinol. Metab. 88 (6): 2784–93. doi:10.1210/jc.2002-021960. PMID 12788888.
  11. Attardi BJ, Hild SA, Koduri S, Pham T, Pessaint L, Engbring J, Till B, Gropp D, Semon A, Reel JR (tháng 10 năm 2010). “The potent synthetic androgens, dimethandrolone (7α,11β-dimethyl-19-nortestosterone) and 11β-methyl-19-nortestosterone, do not require 5α-reduction to exert their maximal androgenic effects”. The Journal of Steroid Biochemistry and Molecular Biology. 122 (4): 212–8. doi:10.1016/j.jsbmb.2010.06.009. PMC 2949447. PMID 20599615.
  12. 1 2 3 García-Becerra R, Ordaz-Rosado D, Noé G, Chávez B, Cooney AJ, Larrea F (2012). “Comparison of 7α-methyl-19-nortestosterone effectiveness alone or combined with progestins on androgen receptor mediated-transactivation”. Reproduction. 143 (2): 211–9. doi:10.1530/REP-11-0171. PMID 22065861.
  13. Attardi BJ, Pham TC, Radler LC, Burgenson J, Hild SA, Reel JR (tháng 6 năm 2008). “Dimethandrolone (7,11β-dimethyl-19-nortestosterone) and 11β-methyl-19-nortestosterone are not converted to aromatic A-ring products in the presence of recombinant human aromatase”. The Journal of Steroid Biochemistry and Molecular Biology. 110 (3–5): 214–22. doi:10.1016/j.jsbmb.2007.11.009. PMC 2575079. PMID 18555683.
  14. Ojasoo T, Delettré J, Mornon JP, Turpin-VanDycke C, Raynaud JP (1987). “Towards the mapping of the progesterone and androgen receptors”. J. Steroid Biochem. 27 (1–3): 255–69. doi:10.1016/0022-4731(87)90317-7. PMID 3695484.
  15. Delettré J, Mornon JP, Lepicard G, Ojasoo T, Raynaud JP (tháng 1 năm 1980). “Steroid flexibility and receptor specificity”. J. Steroid Biochem. 13 (1): 45–59. doi:10.1016/0022-4731(80)90112-0. PMID 7382482.
  16. Raynaud JP, Bouton MM, Moguilewsky M, Ojasoo T, Philibert D, Beck G, Labrie F, Mornon JP (tháng 1 năm 1980). “Steroid hormone receptors and pharmacology”. J. Steroid Biochem. 12: 143–57. doi:10.1016/0022-4731(80)90264-2. PMID 7421203.
  17. Ojasoo T, Raynaud JP, Doé JC (tháng 1 năm 1994). “Affiliations among steroid receptors as revealed by multivariate analysis of steroid binding data”. J. Steroid Biochem. Mol. Biol. 48 (1): 31–46. doi:10.1016/0960-0760(94)90248-8. PMID 8136304.
  18. Raynaud, J.P.; Ojasoo, T.; Bouton, M.M.; Philibert, D. (1979). “Receptor Binding as a Tool in the Development of New Bioactive Steroids”. Drug Design. tr. 169–214. doi:10.1016/B978-0-12-060308-4.50010-X. ISBN 9780120603084.
  19. 1 2 Attardi BJ, Hild SA, Reel JR (tháng 6 năm 2006). “Dimethandrolone undecanoate: a new potent orally active androgen with progestational activity”. Endocrinology. 147 (6): 3016–26. doi:10.1210/en.2005-1524. PMID 16497801. The pharmacokinetic properties of MENT make it unsuitable for once-daily oral treatment or long-term injection; thus, administration by sc implant or by patch or gel is required (27). MENT showed a more rapid metabolic clearance rate than T in men and monkeys, probably due in part to its failure to bind SHBG (28). In monkeys, MENT acetate in subdermal implants was 10 times as potent as T in suppression of gonadotropin secretion and anabolic effects, but was only twice as potent in stimulating prostate growth (29).
  20. Suvisaari J, Sundaram K, Noé G, Kumar N, Aguillaume C, Tsong YY, Lähteenmäki P, Bardin CW (tháng 5 năm 1997). “Pharmacokinetics and pharmacodynamics of 7alpha-methyl-19-nortestosterone after intramuscular administration in healthy men”. Hum. Reprod. 12 (5): 967–73. doi:10.1093/humrep/12.5.967. PMID 9194649.
  21. Kumar N, Didolkar AK, Ladd A, Thau R, Monder C, Bardin CW, Sundaram K (tháng 11 năm 1990). “Radioimmunoassay of 7 alpha-methyl-19-nortestosterone and investigation of its pharmacokinetics in animals”. J. Steroid Biochem. Mol. Biol. 37 (4): 587–91. doi:10.1016/0960-0760(90)90405-a. PMID 2278844.